Progesterone inhibition of dopamine-induced increase in frequency of spontaneous excitatory postsynaptic currents in rat prelimbic cortical neurons

Neuropharmacology

Volumn 46, Issue 2, 2004, Pages 211-222

  Feng, Xue Quan ^a   Dong, Yi ^a   Fu, Ying Mei ^a   Zhu, Yan Hua ^a   Sun, Jian Li ^a   Wang, Zhi ^a   Sun, Feng Yan ^a   Zheng, Ping ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Dopamine; Prelimbic cortex; Progesterone; Spontaneous excitatory postsynaptic current; Whole cell patch clamp; 1 D1 interaction

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; CYCLIC AMP DEPENDENT PROTEIN KINASE; DELTA OPIATE RECEPTOR AGONIST; DOPAMINE 1 RECEPTOR STIMULATING AGENT; PROGESTERONE; PROTEIN KINASE C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; DRUG EFFECT; EXCITATORY POSTSYNAPTIC POTENTIAL; HORMONE ACTION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT;

EID: 0346219338     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2003.08.002     Document Type: Article

References (35)

1. al Dahan M.I., Thalmann R.H. Progesterone regulates gamma-aminobutyric acid B (GABAB) receptors in the neocortex of female rats. Brain Research. 727:1996;40-48.
2. Backstrom T., Hammarback S. Premenstrual syndrome - psychiatric or gynaecological disorder? Annals of Medicine. 23:1991;625-633.
3. Bitran D., Shiekh M., McLeod M. Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors. Journal of Neuroendocrinology. 7:1995;171-177.
4. Bowen W.D., Moses E.L., Tolentino P.J., Walker J.M. Metabolites of haloperidol display preferential activity at sigma receptors compared to dopamine D-2 receptors. European Journal of Pharmacology. 27:1990;111-118.
5. Brand L., Oliver D.W., van der Schyf C.J., Pond S.M., Castagnoli N. Jr. Dopamine receptor binding of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4- oxobutyl]-1,2,3,6-tetrahydropyridine (HPTP), an intermediate metabolite of haloperidol. Life Science. 59:1996;815-820.
6. Brozoski T.J., Brown R.M., Rosvold H.E., Goldman P.S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science. 205:1979;929-932.
7. Cabrera R., Diaz A., Pinter A., Belmar J. In vitro progesterone effects on 3H-dopamine release from rat corpus striatum slices obtained under different endocrine conditions. Life Science. 53:1993;1767-1777.
8. Carr D.B., Sesack S.R. Hippocampal afferents to the rat prefrontal cortex: synaptic targets and relation to dopamine terminals. Journal of Comparative Neurology. 369:1996;1-15.
9. Conde F., Maire-Lepoivre E., Audinat E., Crepel F. Afferent connections of the medial frontal cortex of the rat. II. Cortical and subcortical afferents. Journal of Comparative Neurology. 352:1995;567-593.
10. Delatour B., Gisquet-Verrier P. Prelimbic cortex specific lesions disrupt delayed-variable response tasks in the rat. Behavioral Neuroscience. 110:1996;1282-1298.
11. Falkenstein E., Tillmann H.C., Christ M., Feuring M., Wehling M. Multiple actions of steroid hormones - a focus on rapid, nongenomic effects. Pharmacological Reviews. 52:2000;513-556.
12. Fleischmann A., Makman M.H., Etgen A.M. Ovarian steroids increase veratridine-induced release of amino acid neurotransmitters in preoptic area synaptosomes. Brain Research. 507:1990;161-163.
13. Ichikawa S., Sawada T., Nakamura Y., Morioka H. Ovarian secretion of pregnane compounds during the estrous cycle and pregnancy in rats. Endocrinology. 94:1974;1615-1620.
14. Jentsch J.D., Roth R.H., Taylor J.R. Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action. Progress in Brain Research. 126:2000;433-453.
15. Jinks A.L., McGregor I.S. Modulation of anxiety-related behaviours following lesions of the prelimbic or infralimbic cortex in the rat. Brain Research. 772:1997;181-190.
16. Lindstrom L.H., Gefvert O., Hagberg G., Lundberg T., Bergstrom M., Hartvig P., Langstrom B. Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET. Biological Psychiatry. 46:1999;681-688.
17. Marek G.J., Aghajanian G.K. 5-HT2A receptor or alpha1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. European Journal of Pharmacology. 367:1999;197-206.
18. Maurice T., Urani A., Phan V.L., Romieu P. The interaction between neuroactive steroids and the sigma1 receptor function: behavioral consequences and therapeutic opportunities. Brain Research Review. 37:2001;116-132.
19. Meyer D.A., Carta M., Partridge L.D., Covey D.F., Valenzuela C.F. Neurosteroids enhance spontaneous glutamate release in hippocampal neurons. Possible role of metabotropic sigma1-like receptors. Journal of Biological Chemistry. 277:2002;28725-28732.
20. Murphy B.L., Arnsten A.F., Goldman-Rakic P.S., Roth R.H. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proceedings of the National Academy of Science of the United States of America. 93:1996;1325-1329.
21. Romanides A.J., Duffy P., Kalivas P.W. Glutamatergic and dopaminergic afferents to the prefrontal cortex regulate spatial working memory in rats. Neuroscience. 92:1992;97-106.
22. Romanides A.J., Duffy P., Kalivas P.W. Glutamatergic and dopaminergic afferents to the prefrontal cortex regulate spatial working memory in rats. Neuroscience. 92:1999;97-106.
23. Rupprecht R. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology. 28:2003;139-168.
24. Rupprecht R., Koch M., Montkowski A., Lancel M., Faulhaber J., Harting J., Spanagel R. Assessment of neuroleptic-like properties of progesterone. Psychopharmacology (Berl). 143:1999;29-38.
25. Schmidt P.J., Nieman L.K., Danaceau M.A., Adams L.F., Rubinow D.R. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. The New England Journal of Medicine. 338:1998;209-216.
26. Seamans J.K., Floresco S.B., Phillips A.G. Functional differences between the prelimbic and anterior cingulate regions of the rat prefrontal cortex. Behavioral Neuroscience. 109:1995;1063-1073.
27. Tomogane H., Mizoguchi K., Yokoyama A. Effects of progesterone on concentrations of monoamines in hypothalamic areas and plasma prolactin levels in rats. Proceedings of the Society for Experimental Biology and Medicine. 195:1990;208-212.
28. Tzschentke T.M. Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Progress in Neurobiology. 63:2001;241-320.
29. Wang Z., Zheng P. Characterization of spontaneous excitatory synaptic currents in pyramidal cells of rat prelimbic cortex. Brain Research. 901:2001;303-313.
30. Wang Z., Feng X.Q., Zheng P. Activation of presynaptic D1 dopamine receptors by dopamine increases the frequency of spontaneous excitatory postsynaptic currents through protein kinase A and protein kinase C in pyramidal cells of rat prelimbic cortex. Neuroscience. 112:2002;499-508.
31. Weissman M.M., Olfson M. Depression in women: implications for health care research. Science. 269:1995;799-801.
32. + channel modulation in rodent neurohypophysial nerve terminals by sigma receptors and not by dopamine receptors. Journal of Physiology. 517:1999;391-406.
33. Winn P. Schizophrenia research moves to the prefrontal cortex. Trends in Neuroscience. 17:1994;265-268.
34. Wu F.S., Gibbs T.T., Farb D.H. Inverse modulation of gamma-aminobutyric. Molecular Pharmacology. 37:1990;597-602.
35. Wu F.S., Yu H.M., Tsai J.J. Mechanism underlying potentiation by progesterone of the kainate-induced current in cultured neurons. Brain Research. 779:1998;354-358.